Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 967.46M
March 31, 2026 699.61M
December 31, 2025 621.33M
September 30, 2025 670.00M
June 30, 2025 728.84M
March 31, 2025 799.36M
December 31, 2024 871.30M
September 30, 2024 930.12M
June 30, 2024 772.55M
March 31, 2024 841.44M
December 31, 2023 843.98M
September 30, 2023 906.96M
June 30, 2023 962.02M
March 31, 2023 1.038B
Date Value
December 31, 2022 1.100B
September 30, 2022 1.169B
June 30, 2022 889.42M
March 31, 2022 949.88M
December 31, 2021 1.008B
September 30, 2021 671.62M
June 30, 2021 714.40M
March 31, 2021 771.35M
December 31, 2020 799.83M
September 30, 2020 751.68M
June 30, 2020 348.04M
March 31, 2020 370.27M
December 31, 2019 393.07M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Insmed, Inc. 2.103B
United Therapeutics Corp. 7.220B
AbbVie, Inc. 135.12B
TG Therapeutics, Inc. 1.640B
Travere Therapeutics, Inc. 799.36M

Total Assets (Quarterly) Related Metrics